Now showing items 1-5 of 5

    • Age-Related Adverse Inflammatory and Metabolic Changes Begin Early in Adulthood. 

      Newby, Laura; Bain, James; Parker, Daniel; Sloane, Richard; Pieper, Carl F; Hall, Katherine S; Kraus, Virginia B; ... (12 authors) (The journals of gerontology. Series A, Biological sciences and medical sciences, 2018-05-22)
      Aging is characterized by deleterious immune and metabolic changes, but the onset of these changes is unknown. We measured immune and metabolic biomarkers in adults beginning at age 30. To our knowledge, this is the first ...
    • Foreward 

      Coleman, DL; Dodge, Kenneth A (Middle East Journal of Anesthesiology, 2005-06-01)
    • Foreword 

      Morse, M (2008-01-01)
    • Foreword 

      Douglas, Pamela Susan (2007-10-04)
    • P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes. 

      Povsic, Thomas; Roe, Matthew; Ohman, Erik; Rockhold, Frank; White, Jennifer; Montalescot, Gilles; Cornel, Jan H; ... (15 authors) (JAMA cardiology, 2019-07)
      Importance:Physician behavior in response to knowledge of a patient's CYP2C19 clopidogrel metabolizer status is unknown. Objective:To investigate the association of mandatory reporting of CYP2C19 pharmacogenomic testing, ...